Scott Sagel
Director, Cystic Fibrosis Center · University of Colorado
Credentials: · · ·
History
PresentCystic Fibrosis Center · University of Colorado
- Present
Pediatric Clinical Translational Research Center Core Laboratory · Children's Hospital Colorado
- Present
Center for Biochemical Markers · University of Colorado
Research
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation
New England Journal of Medicine · 2010 · 629 citations
American Journal of Respiratory and Critical Care Medicine · 2014 · 428 citations
Systematic review or meta-analysis · American Journal of Respiratory and Critical Care Medicine · 2018 · 393 citations
32 papers
31 papers
31 papers
- FA
29 papers
29 papers
29 papers
24 papers · 7 as a resident
21 papers
Grants
- 2003–2009
Noninvasive Biomarkers of Proteolytic Activity in CF
National Center for Research Resources · K23
Contact PI · $653.4K · University of Colorado Denver
- 2005–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $102.8K · University of Colorado Denver
Clinical trials
- 2022–2025
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2013–2016
Principal investigator · Completed · Phase 2
University of Colorado, Denver
- 2007–2009
Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis
Principal investigator · Completed · Phase 1, Phase 2
University of Colorado, Denver
- 2004–2008
Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
Principal investigator · Completed · Phase 1, Phase 2
Mallinckrodt